The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis

Qingguo Ruan(University of Pennsylvania), Vasumathi Kameswaran(University of Pennsylvania), Yan Zhang(University of Pennsylvania), Shijun J. Zheng(University of Pennsylvania), Jing Sun(University of Pennsylvania), Junmei Wang(Moffitt Cancer Center), Jennifer DeVirgiliis(University of Pennsylvania), Hsiou‐Chi Liou(Cornell University), Amer A. Beg(Moffitt Cancer Center), Youhai H. Chen(University of Pennsylvania)
The Journal of Experimental Medicine
October 17, 2011
Cited by 243Open Access
Full Text

Abstract

The Th17 cells use the retinoid-related orphan receptor-γ (Rorg or Rorc) to specify their differentiation and lineage-specific function. However, how Rorg is switched on during Th17 differentiation is unknown. We report here that c-Rel and RelA/p65 transcription factors drive Th17 differentiation by binding to and activating two distinct Rorg promoters that control RORγT and RORγ expression, respectively. Similar to RORγT, RORγ is selectively expressed in Th17 cells and is effective in specifying the Th17 phenotype. T cells deficient in c-Rel or RelA are significantly compromised in Th17 differentiation, and c-Rel-deficient mice are defective in Th17 responses. Thus, Th17 immunity is controlled by a Rel-RORγ-RORγT axis, and strategies targeting Rel/NF-κB can be effective for controlling Th17 cell-mediated diseases.


Related Papers

No related papers found

Powered by citation graph analysis